Opportunity, Growth, and the Hidden Risks on the Buy-Side: Investing in Women’s Health
Presented By: Aon / Morrison Cohen LLP
Women’s health is emerging as a compelling—and rapidly evolving—area of investment, driven by innovation, consumer demand, and increased capital flow. As the lines blur between consumer products and regulated healthcare, new complexities are surfacing in diligence and deal execution. This session explores what’s driving momentum, where investors and operators are finding value, and where risk shows up on the buy-side. From product claims and regulatory exposure to transaction liability, learn how experienced dealmakers balance opportunity with discipline.
Moderator:
Partner & Co-Chair, Corporate
Morrison Cohen
Randi Mason helps private investment funds, business owners and executives buy and sell businesses, raise and invest capital and navigate the multitude of daily problems businesses face.
Clients value Randi’s unique combination of legal skills, people savvy and business acumen. She makes a point to listen carefully to her clients’ interests and objectives, devising effective and practical strategies and tactics to purse her clients’ goals. Randi uses her people skills and high EQ to negotiate outcomes that maximize her clients’ interests. Her approach is bolstered by excellent technical skills and deep legal knowledge borne out of decades of advising clients on a vast array of sophisticated and complex legal matters.
Randi’s clients include private equity and venture capital funds, pooled investment vehicles, public companies and mature privately held companies, as well as early- and growth-stage businesses and their founders. She has represented clients in a broad range of industries, including consumer products and services, health and wellness, apparel and accessories, food and beverage, software and technology, medical equipment, industrial manufacturing, and advertising.
Randi joined Morrison Cohen in 2005. She was previously an associate in Weil, Gotshal & Manges LLP's capital markets group.
Panelists:
Managing Director
Aon
Based in New York City, Julia Papastavridis is a Managing Director on Aon's M&A and Transaction Solutions team. Julia is an experienced corporate attorney and M&A insurance broker with a demonstrated history of work in transactional risk in the insurance industry. Julia also brings extensive experience to Aon from her prior positions as a representations & warranties insurance underwriter at AIG and at Everest.
Before joining the insurance industry, Julia was a corporate M&A associate at the law firms of Kramer Levin and Dentons in New York City. Julia earned her J.D. from University of Michigan Law School and M.B.A. from the Institut Administration des Entreprises in Lyon, France.
Founder & Managing Partner
Pontiva Healthcare Partners
Ms. Seltzer is Managing Partner and Founder of Pontiva Healthcare Partners. She has spent 25 years in the healthcare industry and has invested over $550M, resulting in 9 IPOs and M&A exits of $6.9B. Previously, she was a Partner at Gurnet Point Capital, where she led growth equity investments, and at Aisling Capital, a life sciences investment firm. Notable investments include Aimmune Therapeutics (acquired by Nestle Health Sciences), Durata Therapeutics (acquired by Actavis), Miramar Labs (acquired by Sientra), Paratek Pharmaceuticals, Reneo Pharmaceuticals (merged with OnKure), and ZELTIQ Aesthetics (acquired by Allergan).
Prior to Aisling, Ms. Seltzer was an operator at Schering-Plough, where she held roles in business development, marketing and sales, and at Akceli, a biotechnology company developing cell-based microarrays. Ms. Seltzer began her career as a management consultant for McKinsey & Company. She received her M.B.A. from Wharton and an M.S. / B.S. in Molecular Biophysics and Biochemistry from Yale.